0001209191-18-050573.txt : 20180911
0001209191-18-050573.hdr.sgml : 20180911
20180911193229
ACCESSION NUMBER: 0001209191-18-050573
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180910
FILED AS OF DATE: 20180911
DATE AS OF CHANGE: 20180911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DOYLE WILLIAM F
CENTRAL INDEX KEY: 0001194459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36517
FILM NUMBER: 181065806
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Minerva Neurosciences, Inc.
CENTRAL INDEX KEY: 0001598646
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260784194
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 286
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-600-7373
MAIL ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 286
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-09-10
0
0001598646
Minerva Neurosciences, Inc.
NERV
0001194459
DOYLE WILLIAM F
C/O WFD VENTURES LLC
1500 BROADWAY, 17TH FLOOR
NEW YORK
NY
10036
1
0
0
0
Common Stock
2018-09-10
4
P
0
4000
9.88
A
4000
D
Common Stock
2018-09-11
4
P
0
4011
9.72
A
8011
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.75 to $10.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.50 to $9.95, inclusive.
/s/ Matt Bartholomae, Attorney-in-Fact
2018-09-11